Cite Filings / SYRE
Feed Companies Filings Check
Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Filings Financials Insiders Search text
All 823 Financials 221 Shareholder Meetings 15 Executive Compensation 197 Insider Trading 271 Beneficial Ownership Interest 139 Business Combinations 173 Public Offerings 106 Mutual Funds and ETFs 12 Others 83
›
Filed in
  1. No filings match these filters. Clear filters
  2. 8-K Event ● Results of operations 2017-05-09
  3. 8-K Event Regulation FD disclosure 2017-04-21
  4. 8-K Event Regulation FD disclosure 2017-03-24
  5. 8-K Event ● Results of operations 2017-03-23
  6. 8-K Event Regulation FD disclosure 2017-03-23
  7. 8-K Event Regulation FD disclosure 2017-03-06
  8. 8-K Event ● Executive or director change 2017-02-16
  9. 8-K Event ● Results of operations 2016-11-09
  10. 8-K Event Regulation FD disclosure 2016-10-20
  11. 8-K Event ● Results of operations 2016-08-09
  12. 8-K Event ● Results of operations 2016-05-19
  13. 8-K Event Regulation FD disclosure 2016-04-19
  14. 8-K Event Regulation FD disclosure 2016-04-18

Page 9 of 9 · 173 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…